The neurotoxicology program at Charles River encompasses a broad range of products, including pharmaceuticals, biopharmaceuticals, chemicals and agrochemicals, in both rodent and nonrodent species. With over two decades of experience, we have a valuable historical control database for tests in developmental neurotoxicology. We also have a knowledgeable staff of scientists and technical personnel who routinely perform neurotoxicity screening tests for possible on- or off-target effects, specialized target tissue delivery, expanded investigative studies and developmental neurotoxicity.

Capabilities include:

  • Neurobehavior, including assays of locomotor activity, rotarod forced activity, water maze learning and memory testing, auditory startle habituation and functional observational batteries
  • Neurochemistry, including cholinesterase assays in red blood cell, plasma and brain samples, as well as quantification of endogenous levels of neurotransmitters
  • Neuropathology, including in situ perfusion, morphometry, stereology and qualitative neuropathological evaluations
  • Drug abuse/dependence liability testing (non-GLP)
  • Acute neurotoxicity
  • Subchronic neurotoxicity
  • Developmental neurotoxicity
  • Behavioral developmental toxicity
  • Safety pharmacology
  • NMDA receptor antagonist
  • Standard dose routes
  • Routine and specialized routes of parenteral injection or infusion and target-tissue administration
    • Intravenous
    • Subcutaneous
    • Epidural
    • Intrathecal
    • Intracerebroventricular
    • Intracerebral
    • Intracisternal

You may also be interested in...

Miss Us at SOT 2017?

Access the recordings of our four exhibitor sessions and downloadable versions of our poster presentations from SOT 2017.

Cerebrospinal Delivery for Preclinical Research

Access the Source℠ for more information on our experience with cerebrospinal drug delivery, including intrathecal, epidural, intrastriatal, intraputamental, intracerebroventricular and intracisternal administration routes.